Drug Profile
Flecainide/Modafinil - Theranexus
Alternative Names: Modafinil/flecainide - Theranexus; THN-102Latest Information Update: 06 Jan 2023
Price :
$50
*
At a glance
- Originator Theranexus
- Class Benzamides; Benzhydryl compounds; Class Ic antiarrhythmics; Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Central nervous system stimulants; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Narcolepsy
- No development reported Hypersomnia
Most Recent Events
- 02 Jan 2023 No development reported - Phase-II for Hypersomnia in Germany, USA, France, Czech Republic, Hungary (PO)
- 02 Jan 2023 No development reported - Phase-II for Narcolepsy in Belgium (PO)
- 28 Feb 2019 Theranexus completes a phase II trial in Narcolepsy in France and Belgium (PO) (NCT02821715)